Y, B., H, L., S, G., J, L., D, C., X, Z., . . . F, D. (2026). Bispecific antibody-drug conjugates: A modular blueprint for next-generation cancer therapeutics. Archives of pharmacal research, 49(1), 61. https://doi.org/10.1007/s12272-026-01595-z
Chicago Style (17th ed.) CitationY, Bai, et al. "Bispecific Antibody-drug Conjugates: A Modular Blueprint for Next-generation Cancer Therapeutics." Archives of Pharmacal Research 49, no. 1 (2026): 61. https://doi.org/10.1007/s12272-026-01595-z.
MLA (9th ed.) CitationY, Bai, et al. "Bispecific Antibody-drug Conjugates: A Modular Blueprint for Next-generation Cancer Therapeutics." Archives of Pharmacal Research, vol. 49, no. 1, 2026, p. 61, https://doi.org/10.1007/s12272-026-01595-z.
Warning: These citations may not always be 100% accurate.